Account
Inquiry
QSC tirzepatide is a dual GIP and GLP-1 receptor agonist developed for diabetes treatment and weight management research. Our pharmaceutical-grade product meets the highest quality standards for research applications.
The lyophilized white powder formulation ensures excellent stability and long shelf life when stored at 2-8°C. Each batch undergoes rigorous quality control testing including HPLC purity verification and mass spectrometry analysis.
QSC tirzepatide demonstrates superior efficacy in clinical research settings, with studies showing significant improvements in glycemic control and weight reduction. The product is supplied in sterile vials suitable for research applications.
Our manufacturing facility produces QSC tirzepatide under strict GMP conditions, ensuring batch-to-batch consistency and reliable performance in research settings. The product is available in various packaging options to meet different research requirements.
For research purposes only. Not for human consumption. Proper handling procedures should be followed when working with peptide compounds in laboratory settings.
